Scott Keating Email & Phone Number

Boston, MA, US

• Focus on non-opioid pain pharmacotherapy

Lawrence Township, NJ, US

• Served as US indication lead for a CAR T-cell therapy in 3L+ large B-cell lymphoma (LBCL), 2L transplant eligible LBCL, 2L transplant-ineligible LBCL, and mantle cell lymphoma (MCL).
• Independently led the launch of three indications: 3L+ LBCL, 2L transplant eligible LBCL, and 2L transplant ineligible LBCL.
• Collaborate closely with key Medical, Commercial, Access, and customer-facing stakeholders to ensure a strategic initiative aligned, impactful evidence generation plan.
• Led numerous health economic analyses using clinical trial data from single arm and controlled trials, collaborating with leading KOLs as needed.
• Championed development of proactive communication tools including FDAMA 114 content, payer and institutional budget impact models, and burden of illness/unmet need decks.
• Contribute health economic data to core resources such as AMCP dossier, rejection handlers, FAQ/Q&R documents, etc.

Lawrence Township, NJ, US

• Responsible for development of data generation strategy for launching brands, including economic models, budget impact models, cost-effectiveness model adaptations, and patient preference studies.
• Led development of several proactive and reactive customer-facing resources, including training field teams on HEOR analyses.
• Supported submission of New Technology Add-on Payment (NTAP) submission to Centers for Medicare & Medicaid Services.
• Along with US HEOR leadership team, led development of 2021 Mission Statement and key performance indicators.

Lawrence Township, NJ, US

• Developed and executed real-world data generation for in-line brands for multiple myeloma and chronic myeloid leukemia (Nov 2018 – Dec 2019), and launch activities for cell therapies (Jan 2020 onwards).
• Independently designed, executed, and published real-world-data analyses capturing the clinical and economic value of established products.
• Leveraged clinical trial, EMR, registry, and claims data for evidence generation.
• Developed and presented scientific content to key opinion leaders at Medical and Access advisory boards.
• Coordinated with Scientific Content teams on updates to reactive materials and AMCP dossiers; trained field personnel on HEOR analyses.
• Co-lead planning and moderation of department-wide ‘Plan of Action’ meetings.

Leverkusen, North Rhine-Westphalia, DE

• Updated and modified proactive budget impact models.
• Developed and executed statistical analysis plans for claims-based retrospective observational studies.

New York, NY, US

• Designed and executed retrospective observational studies including a systematic literature review.
• Analyzed EHR free text (natural language processing) and claims data using the R programming language.
• Publish findings in peer-reviewed journals, and present scientific content at congresses.

Master'S Degree, Health Policy And Economics

Bachelor Of Science (Bs), Biochemistry And Molecular Biology Bachelor Of Science (Bs), Biology